Displaying drugs 15476 - 15500 of 16351 in total
Empasiprubart
Empasiprubart is a humanized sweeping antibody designed to bind to C2, a protein in the complement cascade that leads to cell destruction when activated.
Investigational
Biomodulin T
Biomodulin T is a polypeptide fraction from bovine thymus with immunomodulatory effects.
Investigational
Lactobacillus fermentum
Experimental
Lactobacillus gasseri
Experimental
Bifidobacterium breve
Experimental
Gentiana lutea extract
Experimental
Bungarus candidus antivenom
Experimental
Wheat germ oil
Experimental
Tetanus immune globulin, equine
Experimental
Liprotamase protease
Experimental
Pygeum africanum bark
Experimental
Paeonia lactiflora root
Experimental
Artemisia annua leaf
Experimental
Citrus aurantium fruit
Experimental
Cinnamon leaf oil
Experimental
Fucus vesiculosus
Experimental
Cryptomeria japonica bark
Experimental
Cnidium monnieri fruit
Experimental
Zagotenemab
Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).
Investigational
Tebotelimab
Tebotelimab is under investigation in clinical trial NCT04082364 (Combination Margetuximab, INCMGA00012, MGD013, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/gej Cancer (MAHOGANY)).
Investigational
Matched Description: … is under investigation in clinical trial NCT04082364 (Combination Margetuximab, INCMGA00012, MGD013, and …
Lanacogene vosiparvovec
Experimental
Zildistrogene varoparvovec
Experimental
Ezaladcigene resoparvovec
Investigational
Avalotcagene ontaparvovec
Investigational
Cobnabexagene anvuparvovec
Experimental
Displaying drugs 15476 - 15500 of 16351 in total